Form4insider filings, from the source

SEC Form 4 · accession 0001127602-17-009398

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
James F Tessmer
Officer — VP, Finance & Accounting
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 6:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 28, 2017M857—A16,803D
Common StockF1Feb 28, 2017M1,339—A18,142D
Common StockF1Feb 28, 2017M2,668—A20,810D
Common StockF1Feb 28, 2017M2,075—A22,885D
Common StockFeb 28, 2017F2,790$16.45D20,095D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Feb 28, 2017M857D——Common Stock8570D
Restricted Stock Units (Phantom Stock)F1,F4—Feb 28, 2017M1,339D——Common Stock1,3391,340D
Restricted Stock Units (Phantom Stock)F1,F5—Feb 28, 2017M2,668D——Common Stock2,6685,336D
Restricted Stock Units (Phantom Stock)F1,F6—Feb 28, 2017M2,075D——Common Stock2,0756,225D

Explanation of responses